tradingkey.logo

Solid Biosciences Inc <SLDB.OQ> expected to post a loss of 50 cents a share - Earnings Preview

ReutersAug 8, 2025 9:25 PM
  • Solid Biosciences Inc SLDB.OQ SLDB.O is expected to show no change in quarterly revenue when it reports results on August 11 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for Solid Biosciences Inc is for a loss of 50 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Solid Biosciences Inc is $16.00, about 61.3% above its last closing price of $6.19

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2025

-0.53

-0.56

-0.59

Missed

-6.1

Dec. 31 2025

-0.81

-0.81

-1.00

Missed

-24

Sep. 30 2024

-0.66

-0.67

-0.79

Missed

-18.3​

Jun. 30 2024

-0.66

-0.66

-0.61

Beat

8.1

​​Mar. 31 2024

-0.65

-0.64

-0.64

Met

-0.1

Dec. 31 2023

-1.04

-0.99

-1.00

Missed

-1.2​

Sep. 30 2023

-1.19

-1.19

-1.05

Beat

11.6

Jun. 30 2023

-1.55

-1.53

-1.25

Beat

18.6

This summary was machine generated August 8 at 21:25 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI